US Stock MarketDetailed Quotes

BioLine Rx (BLRX)

Watchlist
  • 2.670
  • +0.010+0.38%
Close Mar 13 16:00 ET
  • 2.670
  • 0.0000.00%
Post 20:01 ET
11.62MMarket Cap0.00P/E (TTM)

BioLine Rx (BLRX) Revenue Breakdown Overview

By Business/Source

Currency:USD
2024/FY
Stock NameRevenueRatio
Development and commercialization of therapeutics.28.94M100.00%

By Country/Region

Currency:USD
2024/FY
Stock NameRevenueRatio
China14.96M51.68%
United States (U.S.)13.98M48.32%
Market Insights
Nancy Pelosi Portfolio
China Concept Stocks
View More
Middle East conflict spreads to the stock market! How should investors respond?
Recently, the ongoing conflict between the US and Iran has continued to disrupt the stock market. On March 11 local time, Trump once again s Show More